Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM P/E Multiple | -24.5x - -27.1x | -25.8x |
| Selected Fwd P/E Multiple | 60.1x - 66.4x | 63.3x |
| Fair Value | A$0.54 - A$0.60 | A$0.57 |
| Upside | -37.4% - -30.8% | -34.1% |
| Benchmarks | - | Full Ticker |
| HeraMED Limited | - | ASX:HMD |
| Nanosonics Limited | - | ASX:NAN |
| Micro-X Limited | - | ASX:MX1 |
| Resonance Health Limited | - | ASX:RHT |
| Nova Eye Medical Limited | - | ASX:EYE |
| CleanSpace Holdings Limited | - | ASX:CSX |
| - | - | - |
| Select Price / LTM EPS Ratio | ||||||||
| Benchmark Companies | ||||||||
| HMD | NAN | MX1 | RHT | EYE | CSX | |||
| ASX:HMD | ASX:NAN | ASX:MX1 | ASX:RHT | ASX:EYE | ASX:CSX | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | NM- | -0.9% | NM- | -33.2% | NM- | NM- | ||
| 3Y CAGR | NM- | 14.8% | NM- | -33.9% | NM- | NM- | ||
| Latest Twelve Months | 19.0% | 5.6% | 25.7% | 71.5% | 40.2% | 72.9% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | -4237.0% | 8.4% | -191.4% | -8.4% | 1.1% | -27.8% | ||
| Prior Fiscal Year | -1117.6% | 12.0% | -71.7% | -17.7% | -89.8% | -67.2% | ||
| Latest Fiscal Year | -1507.0% | 7.6% | -64.2% | 2.0% | -37.7% | -19.9% | ||
| Latest Twelve Months | -1507.0% | 9.0% | -76.3% | -2.9% | -32.8% | -8.4% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | -2.7x | 63.1x | -3.3x | -15.0x | -7.2x | -29.0x | ||
| Price / LTM Sales | 48.1x | 6.6x | 3.7x | 1.7x | 1.5x | 3.8x | ||
| LTM P/E Ratio | -3.2x | 73.3x | -4.8x | -57.9x | -4.7x | -45.6x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/E Ratio | -57.9x | -4.7x | 73.3x | |||||
| Historical LTM P/E Ratio | -6.2x | -3.1x | 7.5x | |||||
| Selected P/E Multiple | -24.5x | -25.8x | -27.1x | |||||
| (x) LTM Net Income | (1) | (1) | (1) | |||||
| (=) Equity Value | 36 | 38 | 40 | |||||
| (/) Shares Outstanding | 78.3 | 78.3 | 78.3 | |||||
| Implied Value Range | 0.46 | 0.49 | 0.51 | |||||
| FX Rate: AUD/AUD | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 0.46 | 0.49 | 0.51 | 0.86 | ||||
| Upside / (Downside) | -46.2% | -43.4% | -40.5% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | HMD | NAN | MX1 | RHT | EYE | CSX | |
| Value of Common Equity | 18 | 1,215 | 52 | 18 | 40 | 67 | |
| (/) Shares Outstanding | 875.6 | 303.6 | 667.2 | 459.6 | 284.5 | 78.3 | |
| Implied Stock Price | 0.02 | 4.00 | 0.08 | 0.04 | 0.14 | 0.86 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 0.02 | 4.00 | 0.08 | 0.04 | 0.14 | 0.86 | |
| Trading Currency | AUD | AUD | AUD | AUD | AUD | AUD | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |